Antineutrophil Cytoplasmic Antibodies (ANCA) in Rheumatoid Arthritis: a Prospective Study

Overview

Journal Rheumatol Int

Specialty Rheumatology

Date 1996 Jan 1

PMID 8778951

Citations 9

Authors

E Rother

T Schochat

H H Peter

Affiliations

Soon will be listed here.

Abstract

To investigate a possible relationship between the presence of antineutrophil cytoplasmic antibodies (ANCA), rheumatoid factor (RF), antinuclear antibodies (ANA), complement, disease activity and disease severity, 111 clinically well-documented RA patients were studied prospectively for ANCA, RF, ANA, C-reactive protein (CRP), total haemolytic complement (CH50) and complement split product C3d. Disease activity and severity were also assessed clinically, as well as anamnestically, using the Hannover Activity of Daily Living Questionnaire, the functional Steinbrocker grades, and numeric and verbal rating scales. At a serum dilution of 1:50, 20% of the 111 sera showed predominantly an atypical perinuclear staining pattern. There was no correlation between ANCA positivity and serological markers, disease activity and disease severity. Regarding previous therapies with disease-modifying antirheumatic drugs, ANCA+ patients took sulphasalazine significantly more often than ANCA- patients.

Citing Articles

Prevalence and clinical association of the presence of anti-neutrophilic cytoplasmic antibody in systemic sclerosis.

Mahakkanukrauh A, Suwannaroj S, Nanagara R, Foocharoen C Arch Med Sci. 2021; 17(6):1696-1705.

PMID: 34900051 PMC: 8641511. DOI: 10.5114/aoms.2019.85172.

Patients with ANCA-Associated Glomerulonephritis and Connective Tissue Diseases: A Comparative Study from the Maine-Anjou AAV Registry.

Guibert F, Garnier A, Wacrenier S, Piccoli G, Djema A, Gansey R J Clin Med. 2019; 8(8).

PMID: 31416296 PMC: 6723780. DOI: 10.3390/jcm8081218.

Anti-PR3 and anti-MPO antibodies are not present in sera of patients with pulmonary tuberculosis.

Lima I, Oliveira R, Cabral M, Atta A, Marchi S, Reis E Rheumatol Int. 2014; 34(9):1231-4.

PMID: 24719228 DOI: 10.1007/s00296-014-3009-z.

Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: two case reports and review of literature.

Spoerl D, Pers Y, Jorgensen C Allergy Asthma Clin Immunol. 2012; 8(1):19.

PMID: 23253567 PMC: 3552688. DOI: 10.1186/1710-1492-8-19.

Anti-neutrophil cytoplasmic antibodies in leprosy.

Barros Edington F, Bacellar M, Machado P, Barbosa L, Reis E, Reis M Clin Rheumatol. 2006; 26(2):208-10.

PMID: 16572282 DOI: 10.1007/s10067-006-0281-7.

References

Brandslund I, Siersted H, Svehag S, Teisner B . Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma. J Immunol Methods. 1981; 44(1):63-71. DOI: 10.1016/0022-1759(81)90107-1. View

Coremans I, Hagen E, Daha M, van der Woude F, van der Voort E, Breedveld F . Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum. 1992; 35(12):1466-75. DOI: 10.1002/art.1780351210. View

Tervaert J, Goldschmeding R, ELEMA J, Limburg P, VAN DER GIESSEN M, Huitema M . Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum. 1990; 33(8):1264-72. DOI: 10.1002/art.1780330829. View

Scott D . Clinical measurements in rheumatology. Br J Rheumatol. 1987; 26(2):81-3. DOI: 10.1093/rheumatology/26.2.81. View

Bosch X, Llena J, Font J, Collado A, Mirapeix E, Urbano-Marquez A . Anti-granulocyte perinuclear antibodies but not anti-neutrophil cytoplasmic antibodies (ANCA) in rheumatoid arthritis. Adv Exp Med Biol. 1993; 336:375-80. DOI: 10.1007/978-1-4757-9182-2_64. View

Nolle B, Specks U, Ludemann J, Rohrbach M, DeRemee R, Gross W . Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med. 1989; 111(1):28-40. DOI: 10.7326/0003-4819-111-1-28. View

Savige J, Gallicchio M, Stockman A, Cunningham T, Rowley M, Georgiou T . Anti-neutrophil cytoplasm antibodies in rheumatoid arthritis. Clin Exp Immunol. 1991; 86(1):92-8. PMC: 1554154. DOI: 10.1111/j.1365-2249.1991.tb05779.x. View

Faber V, Elling P . Leucocyte-specific anti-nuclear factors in patients with felty's syndrome, rheumatoid arthritis, systemic lupus erythematosus and other diseases. Acta Med Scand. 1966; 179(3):257-67. DOI: 10.1111/j.0954-6820.1966.tb05457.x. View

Wiik A . Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis. Allergy. 1980; 35(4):263-89. DOI: 10.1111/j.1398-9995.1980.tb01768.x. View

10.

Mulder A, Horst G, Haagsma E, Kleibeuker J, Kallenberg C . Anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver disease. Adv Exp Med Biol. 1993; 336:545-9. DOI: 10.1007/978-1-4757-9182-2_99. View

11.

Martensson U, Nassberger L . Circulating autoantibodies directed against beta-glucuronidase. Autoimmunity. 1992; 11(3):213-4. DOI: 10.3109/08916939209035157. View

12.

Falk R, Jennette J . Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988; 318(25):1651-7. DOI: 10.1056/NEJM198806233182504. View

13.

Nishiya K, Oohara E, Ooishi N, Moriki T, Kageoka T, Sasaki M . [Detection of antineutrophil cytoplasmic antibodies in sera from patients with rheumatoid arthritis by indirect immunofluorescence technique]. Rinsho Byori. 1994; 42(2):176-82. View

14.

Charles P, Maini R . Antibodies to neutrophil cytoplasmic antigens in rheumatoid arthritis. Adv Exp Med Biol. 1993; 336:367-70. DOI: 10.1007/978-1-4757-9182-2_62. View

15.

Spickett G, Broomhead V . Formalin fixation and patterns of antineutrophil cytoplasmic antibodies. J Clin Pathol. 1995; 48(1):89-90. PMC: 502272. DOI: 10.1136/jcp.48.1.89. View

16.

Ludemann J, Utecht B, Gross W . Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med. 1990; 171(1):357-62. PMC: 2187669. DOI: 10.1084/jem.171.1.357. View

17.

Rother E, Metzger D, Lang B, Melchers I, Peter H . Anti-neutrophil cytoplasm antibodies (ANCA) in rheumatoid arthritis: relationship to HLA-DR phenotypes, rheumatoid factor, anti-nuclear antibodies and disease severity. Rheumatol Int. 1994; 14(4):155-61. DOI: 10.1007/BF00579701. View

18.

STEINBROCKER O, TRAEGER C, BATTERMAN R . Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc. 1949; 140(8):659-62. DOI: 10.1001/jama.1949.02900430001001. View

19.

Peter H, Metzger D, Rump A, Rother E . ANCA in diseases other than systemic vasculitis. Clin Exp Immunol. 1993; 93 Suppl 1:12-4. PMC: 1554934. DOI: 10.1111/j.1365-2249.1993.tb06217.x. View

20.

Gross W, Ludemann G, Kiefer G, Lehmann H . Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet. 1986; 1(8484):806. DOI: 10.1016/s0140-6736(86)91820-9. View